$AMGN
Amgen Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is AMGN up today? It is at $433.73 (+0.00%), and our scanner flagged it 53 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AMGN spikes, and full due diligence on AMGN — key stats, earnings, dilution and insider activity. Free.
Get free $AMGN alerts the moment volume spikes
Our scanner flagged $AMGN 53 times in the last 30 days. Create a free account to track $AMGN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $433.73
- Change today
- +0.00%
- Previous close
- $433.73
- 52-week range
- $269.77 – $443.20
- Market cap
- $234.49B
- P/E ratio
- 30.83
- Dividend yield
- 2.28% ($10.08)
- Shares outstanding
- 540.6M
- Institutional own.
- 93.55%
- Total held
- 94.1%
- Tradeable float
- 32.1M 6% of shares · after <1% insiders + 94% institutions
- Short interest
- 13.3M ▲ +3% vs prior · as of 2026-07-31
- Short % of float
- 41.3%
- Days to cover
- 5.2d
- Avg daily volume
- 2.7M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 2.7x
- 15mthin
- 3.2x
- 1hthin
- 3.2x
- 1D
- 0.0x
Get free AMGN + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $AMGN moving today?
Here is the latest on AMGN from our scanner (live price and day move above). A recent catalyst in the news: “IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?.”
Analyst data via Nasdaq. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
Insiders
Insiders buying4 buys, 4 sells last 3 months (42/58 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Khosla Rachna Officer | Sold (automatic/other) | -1K | sold 16% | 6K | $521K at $416.43 | Aug 13, 26 |
Khosla Rachna Officer | Other | 1K | added 20% | 8K | $204K at $162.60 | Aug 13, 26 |
Khosla Rachna Officer | Sold (automatic/other) | -2K | sold 24% | 6K | $825K at $412.57 | Aug 11, 26 |
Drake Michael V Director | Acquired (grant/award) | +64 | added 1.1% | 6K | n/a | Aug 7, 26 |
Holley Charles M Director | Acquired (grant/award) | +103 | added 0.8% | 13K | n/a | Aug 7, 26 |
Ishrak Omar Director | Acquired (grant/award) | +85 | added 1.1% | 7K | n/a | Aug 7, 26 |
Busch Matthew C. Officer | Acquired (grant/award) | +730 | added 17% | 5K | n/a | Aug 7, 26 |
Grygiel Nancy A. Officer | Sold (automatic/other) | -3K | sold 29% | 7K | $1.2M at $402.16 | Aug 6, 26 |
Grygiel Nancy A. Officer | Other | 3K | added 47% | 9K | $527K at $177.31 | Aug 6, 26 |
Miller Derek Officer | Sold (automatic/other) | -4K | sold 24% | 12K | $1.6M at $402.54 | Aug 6, 26 |
Miller Derek Officer | Other | 4K | added 37% | 15K | $633K at $162.60 | Aug 6, 26 |
Austin Wanda M Director | Acquired (grant/award) | +665 | added 9.0% | 8K | n/a | May 19, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $AMGN runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- About $4.0B in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$AMGN Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$AMGN Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to AMGN
Comparable names in biological products, (no diagnostic substances), closest in size first.
AMGN is in these themes
Curated groups AMGN belongs to. Tap one to see every member with today's move and why the group is moving.
AMGN stock FAQ
Why is $AMGN moving today?
Here is the latest on AMGN from our scanner (live price and day move above). A recent catalyst in the news: “IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?.”
What is the AMGN stock price today?
AMGN last traded at $433.73, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Does AMGN pay a dividend?
Yes. AMGN currently has a dividend yield of about 2.28% ($10.08 per share per year). Dividend figures can change; this is not investment advice.
Where can I see live AMGN alerts?
The AMGN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AMGN 53 times in the last 30 days.
What exchange is AMGN on?
AMGN (Amgen Inc) trades on XNAS, with a market cap of about $234.49B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is AMGN good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AMGN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.